|
Alliance News
|
|
| Due
Diligence Checklist
- CEO-Notes Newsletter - Partnering
Tools - PartneringAgreements.com
Alliance Answer Board - Pages 1 2 3 4 5 6 7 8 9 10 11 12 more |
Posted by Lawrence Christopher
Looking for a partnership to share completed R&D, marketing,
Natural Expo show exhibit(June 4th & 5th 2003)Amsterdam Rai Conference Center, inventory and certificiations (BTI European Union,Canadian FDA approved). Total up front investment of $275,000 USD. We are approved to distribute to
most of Europe via EU. $48 BILLION DOLLAR European industry only. Serious inquiries only. Last year 2002, Glaxo/SmithKline Pharmaceuticals grossed $513 Million USD worldwide sales with only the patch and gum. Glaxo/SnithKline unvieled their newest stop smoking nicotine based lozenge "Comitt".
This validates a giant pharmaceutical getting FDA approval
of an "oral" lozenge administering.
Nicodrops is a NON NICOTINE BASED 100% mint flavored lozenge. A No Nonsense approach that attacks the "Craving"
with immediate results without the using the nicotine based
gum, patch and lozenge. For more information please review
our website at www.nicodrops.com.
Contact: Lawrence Christopher email: nicodrops@earthlink.net
619-461-6014.